Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit

Clinical Microbiology and Infection

Volumn 17, Issue 8, 2011, Pages 1201-1208

  Nseir, S ^a,b   Blazejewski, C ^a   Lubret, R ^a   Wallet, F ^a   Courcol, R ^a   Durocher, A ^a,b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

Author keywords

Acinetobacter baumannii; Colonization; Environmental contamination; Extended spectrum lactamase; Gram negative bacilli; Multidrug resistant bacteria; Pseudomonas aeruginosa; Room cleaning

Indexed keywords

CEFTAZIDIME; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM;

ACINETOBACTER BAUMANNII; ADULT; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL COLONIZATION; FEMALE; GRAM NEGATIVE BACTERIUM; HOSPITALIZATION; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; RISK FACTOR; SEDATION; TRACHEOSTOMY;

ACINETOBACTER BAUMANNII; BACILLI (CLASS); NEGIBACTERIA; PSEUDOMONAS AERUGINOSA;

EID: 79958707969     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03420.x     Document Type: Article

References (45)

1. Vincent JL, Rello J, Marshall J et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009; 302: 2323-2329.
2. Nseir S, Deplanque X, Di Pompeo C et al. Risk factors for relapse of ventilator-associated pneumonia related to nonfermenting Gram negative bacilli: a case-control study. J Infect 2008; 56: 319-325.
3. Niederman MS. Use of broad-spectrum antimicrobials for the treatment of pneumonia in seriously ill patients: maximizing clinical outcomes and minimizing selection of resistant organisms. Clin Infect Dis 2006; 42 (Suppl 2): S72-S81.
4. Parker CM, Kutsogiannis J, Muscedere J et al. Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: prevalence, incidence, risk factors, and outcomes. J Crit Care 2008; 23: 18-26.
5. Slama TG. Gram-negative antibiotic resistance: there is a price to pay. Crit Care 2008; 12 (Suppl 4): S4.
6. Chastre J. Evolving problems with resistant pathogens. Clin Microbiol Infect 2008; 14 (Suppl 3): 3-14.
7. Hota B. Contamination, disinfection, and cross-colonization: are hospital surfaces reservoirs for nosocomial infection? Clin Infect Dis 2004; 39: 1182-1189.
8. Dancer SJ. Importance of the environment in methicillin-resistant Staphylococcus aureus acquisition: the case for hospital cleaning. Lancet Infect Dis 2008; 8: 101-113.
9. Huang SS, Datta R, Platt R. Risk of acquiring antibiotic-resistant bacteria from prior room occupants. Arch Intern Med 2006; 166: 1945-1951.
10. Drees M, Snydman DR, Schmid CH et al. Prior environmental contamination increases the risk of acquisition of vancomycin-resistant enterococci. Clin Infect Dis 2008; 46: 678-685.
11. Nseir S, Grailles G, Soury-Lavergne A et al. Accuracy of American Thoracic Society/Infectious Diseases Society of America criteria in predicting infection or colonization with multidrug-resistant bacteria at intensive-care unit admission. Clin Microbiol Infect 2010; 16: 902-908.
12. McCabe WR, Jackson GG. Gram-negative bacteremia. Etiology and ecology. Arch Intern Med 1962; 110: 847-855.
13. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-946.
14. Nseir S, Di Pompeo C, Diarra M et al. Relationship between immunosuppression and intensive care unit-acquired multidrug-resistant bacteria: a case-control study. Crit Care Med 2007; 35: 1318-1323.
15. Martinez JA, Ruthazer R, Hansjosten K et al. Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit. Arch Intern Med 2003; 163: 1905-1912.
16. Shaughnessy M, Micielli R, Depestel D et al. Evaluation of hospital room assignment and acquisition of Clostridium difficile-associated diarrhea. Programs and abstracts of the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)/Infectious Diseases Society of America (IDSA) 46th Annual Meeting. Washington 2008. Abstract K-4194.
17. Olson B, Weinstein RA, Nathan C et al. Epidemiology of endemic Pseudomonas aeruginosa: why infection control efforts have failed. J Infect Dis 1984; 150: 808-816.
18. Cholley P, Thouverez M, Floret N et al. The role of water fittings in intensive care rooms as reservoirs for the colonization of patients with Pseudomonas aeruginosa. Intensive Care Med 2008; 34: 1428-1433.
19. Cuttelod M, Senn L, Terletskiy V et al. Molecular epidemiology of Pseudomonas aeruginosa in intensive care units (ICUs) over a 10-year period (1998-2007). Clin Microbiol Infect 2010; DOI:.
20. Simor AE, Lee M, Vearncombe M et al. An outbreak due to multiresistant Acinetobacter baumannii in a burn unit: risk factors for acquisition and management. Infect Control Hosp Epidemiol 2002; 23: 261-267.
21. Das I, Lambert P, Hill D et al. Carbapenem-resistant Acinetobacter and role of curtains in an outbreak in intensive care units. J Hosp Infect 2002; 50: 110-114.
22. Boyce JM, Potter-Bynoe G, Chenevert C et al. Environmental contamination due to methicillin-resistant Staphylococcus aureus: possible infection control implications. Infect Control Hosp Epidemiol 1997; 18: 622-627.
23. Hayden MK, Blom DW, Lyle EA et al. Risk of hand or glove contamination after contact with patients colonized with vancomycin-resistant enterococcus or the colonized patients' environment. Infect Control Hosp Epidemiol 2008; 29: 149-154.
24. Bhalla A, Pultz NJ, Gries DM et al. Acquisition of nosocomial pathogens on hands after contact with environmental surfaces near hospitalized patients. Infect Control Hosp Epidemiol 2004; 25: 164-167.
25. Harris AD, McGregor JC, Furuno JP. What infection control interventions should be undertaken to control multidrug-resistant gram-negative bacteria? Clin Infect Dis 2006; 43 (Suppl 2): S57-S61.
26. Hardy KJ, Oppenheim BA, Gossain S et al. A study of the relationship between environmental contamination with methicillin-resistant Staphylococcus aureus (MRSA) and patients' acquisition of MRSA. Infect Control Hosp Epidemiol 2006; 27: 127-132.
27. Panagea S, Winstanley C, Walshaw MJ et al. Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre, and study of its survival on dry surfaces. J Hosp Infect 2005; 59: 102-107.
28. Jawad A, Seifert H, Snelling AM et al. Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates. J Clin Microbiol 1998; 36: 1938-1941.
29. Hirai Y. Survival of bacteria under dry conditions; from a viewpoint of nosocomial infection. J Hosp Infect 1991; 19: 191-200.
30. Carling PC, Parry MF, Bruno-Murtha LA et al. Improving environmental hygiene in 27 intensive care units to decrease multidrug-resistant bacterial transmission. Crit Care Med 2010; 38: 1054-1059.
31. Barbut F, Menuet D, Verachten M et al. Comparison of the efficacy of a hydrogen peroxide dry-mist disinfection system and sodium hypochlorite solution for eradication of Clostridium difficile spores. Infect Control Hosp Epidemiol 2009; 30: 507-514.
32. Bartels MD, Kristoffersen K, Slotsbjerg T et al. Environmental methicillin-resistant Staphylococcus aureus (MRSA) disinfection using dry-mist-generated hydrogen peroxide. J Hosp Infect 2008; 70: 35-41.
33. Ray A, Perez F, Beltramini AM et al. Use of vaporized hydrogen peroxide decontamination during an outbreak of multidrug-resistant Acinetobacter baumannii infection at a long-term acute care hospital. Infect Control Hosp Epidemiol 2010; 31: 1236-1241.
34. French GL, Otter JA, Shannon KP et al. Tackling contamination of the hospital environment by methicillin-resistant Staphylococcus aureus (MRSA): a comparison between conventional terminal cleaning and hydrogen peroxide vapour decontamination. J Hosp Infect 2004; 57: 31-37.
35. Hardy KJ, Gossain S, Henderson N et al. Rapid recontamination with MRSA of the environment of an intensive care unit after decontamination with hydrogen peroxide vapour. J Hosp Infect 2007; 66: 360-368.
36. Nerandzic M, Cadnum J, Plutz M et al. Evaluation of an automated ultraviolet radiation device for decontamination of healthcare-associated pathogens in hospital rooms. ICAAC 2009 Abstract K-2107a.
37. Po JL, Carling PC. The need for additional investigation of room decontamination processes. Infect Control Hosp Epidemiol 2010; 31: 776-777.
38. Lin MF, Huang ML, Lai SH. Risk factors in the acquisition of extended-spectrum β-lactamase Klebsiella pneumoniae: a case-control study in a district teaching hospital in Taiwan. J Hosp Infect 2003; 53: 39-45.
39. Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev 2005; 18: 657-686.
40. Caricato A, Montini L, Bello G et al. Risk factors and outcome of Acinetobacter baumanii infection in severe trauma patients. Intensive Care Med 2009; 35: 1964-1969.
41. Garau J, Gomez L. Pseudomonas aeruginosa pneumonia. Curr Opin Infect Dis 2003; 16: 135-143.
42. Paramythiotou E, Lucet JC, Timsit JF et al. Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units: role of antibiotics with antipseudomonal activity. Clin Infect Dis 2004; 38: 670-677.
43. Falagas ME, Kopterides P. Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature. J Hosp Infect 2006; 64: 7-15.
44. El Solh AA, Alhajhusain A. Update on the treatment of Pseudomonas aeruginosa pneumonia. J Antimicrob Chemother 2009; 64: 229-238.
45. Obritsch MD, Fish DN, MacLaren R et al. Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options. Pharmacotherapy 2005; 25: 1353-1364.